Skip to main content
The British Journal of Radiology logoLink to The British Journal of Radiology
. 2024 Feb 24;97(1158):1067–1077. doi: 10.1093/bjr/tqae048

MRI predictors of long-term outcomes of neonatal hypoxic ischaemic encephalopathy: a primer for radiologists

Sheng-Che Hung 1,, Yi-Fang Tu 2, Senyene E Hunter 3, Carolina Guimaraes 4
PMCID: PMC11654721  PMID: 38407350

Abstract

This review aims to serve as a foundational resource for general radiologists, enhancing their understanding of the role of Magnetic Resonance Imaging (MRI) in early prognostication for newborns diagnosed with hypoxic ischaemic encephalopathy (HIE). The article explores the application of MRI as a predictive instrument for determining long-term outcomes in newborns affected by HIE. With HIE constituting a leading cause of neonatal mortality and severe long-term neurodevelopmental impairments, early identification of prognostic indicators is crucial for timely intervention and optimal clinical management. We examine current literature and recent advancements to provide an in-depth overview of MRI predictors, encompassing brain injury patterns, injury scoring systems, spectroscopy, and diffusion imaging. The potential of these MRI biomarkers in predicting long-term neurodevelopmental outcomes and the probability of epilepsy is also discussed.

Keywords: hypoxic-ischaemic encephalopathy, neonatal encephalopathy, hypothermia, therapeutic hypothermia, outcome, MRI

Introduction

Hypoxic-ischaemic encephalopathy (HIE) is a significant source of mortality and disability in neonates caused by hypoxia and ischaemia to the neonate’s brain.1 Neonatal brain hypoxia and ischaemia can occur during the antenatal, intrapartum, or postnatal period, and may result in severe neurological complications, including cerebral palsy, epilepsy, developmental delays, and cognitive impairment.1 Therapeutic hypothermia (TH) is an effective and safe intervention, significantly mitigating mortality and disability in moderate to severe HIE cases. Nonetheless, 30%-70% of affected neonates have an early death or survive with neurological impairments.2–5 Therefore, it is imperative to establish reliable parameters to assess the extent and severity of brain injury during the subacute period following hypothermia. These parameters could guide management of required adjuvant therapies, like duration of seizure management in patients with extensive injury on MRI or the choice of appropriate neurorehabilitation for specific brain injuries. Additionally, they could serve as early indicators of the effectiveness of TH and aid in the assessment of preclinical and clinical trials for emerging neuroprotective treatments, such as erythropoietin and allopurinol.6 Early and accurate predictors of long-term neurodevelopmental outcomes (LTNO) are essential for prognostication and comprehensive family counseling post-HIE.

MRI, by virtue of its non-invasive, high-resolution imaging capabilities, can elucidate pathological changes otherwise undetectable via clinical assessment or alternative imaging techniques. A plethora of studies have underscored the predictive merit of MRI in determining neonatal HIE outcomes.7–9 Nonetheless, the widespread clinical applicability of MR’s prognostic value is curtailed by heterogeneity in imaging techniques, timing of assessments, follow-up durations, and thresholds for unfavourable outcomes of the index test.7

The objective of this review is to offer a foundational resource for radiologists, detailing the most contemporary and frequently utilized semi-quantitative and quantitative methodologies for evaluating HIE injuries in term and near-term infants (gestational age ≥35 weeks) after TH and their prognostic implications. This review emphasizes the associations between MRI and long-term follow-ups, wherein neonates are followed until they reach or exceed 18 months of age, given the challenges in accurately assessing neurological sequela in neonates younger than 12 months and the observations that mental and behavioural disabilities may present even later.10

Long-term neurodevelopmental outcomes

Research on the long-term neurodevelopmental impacts in infants suffering from HIE frequently utilizes composite outcomes as the outcome measures. These composite outcomes are categorized into favourable or unfavourable/adverse groups, but definitions can vary markedly across studies, primarily depending on the neuropsychiatric assessment instruments used. Adverse or unfavourable outcomes are generally identified by one or more of the following: mortality, cerebral palsy, detectable developmental delay using validated tools such as IQ tests or the Bayley Scales of Infant and Toddler Development, intractable epilepsy, or vision and hearing impairments. Notably, the exact criteria for these outcomes can fluctuate among different studies (Table 1). Moreover, several meta-analyses have consistently affirmed the reliability of MRI in predicting these adverse outcomes.7,9

Table 1.

Characteristics of studies using MRI predicting long-term neurodevelopmental outcomes (modified from Ouwehand et al9).

Study Timing of MRI, days n/N* HIE grade** Follow-up, months Adverse outcome, % Definitions of adverse outcome Predictors
Shankaran et al17 14.7 ± 10.6 73/73 0/54/18 18-22 30 Death, BSID-II < 85, GMFCS 2-5, HI, VI, epilepsy NICHD NRN score
Shankaran et al54 15.3 ± 12.3 69/69 NR 72-84 32 Death, IQ < 70 NICHD NRN score
Alderliesten et al39 4.7 ± 1.3 65/65 6/47/12 18 28 Death, GMDS < 85, CP ADC of posterior corpus callosum
Charon et al30 4 (3-6) (first MRI), 11 (7-21) (second MRI)†† 38/43 0/17/14 24 21 Death, revised Brunet-Lezine score < 70, GMFCS 3-5 Signal abnormalities of PLIC on first or second MRI
Weeke et al55 6.4 ± 2.9 22/26 0/17/7 24 50 Death, BSID-III < 85, GMFCS 2-5, epilepsy, moderate to severe disability Adapted Barkovich score
Alderliesten et al27 Within 7 days††† 88/88 10/62/16 24 33 Death, BSID-III < 85, CP, VI, HI ADC of BGT, Lactate/NAA ratio of left BGT (> 0.4)
Heursen et al31 4-6††† 54/54 10/29/15 24 33 Death, BSID-III < 70, GMFCS 2-5 ADC of PLIC and thalami
Barta et al38 Within 4 days††† 51/68 0/5/46 18-26 31 Death, BSID-II < 70 MRS (left thalamus); mIns/NAA (≥ 0.6798) is the best predictor
Weeke et al51 Within 7 days††† 173/173 16/129/25 24, 66-96 (school age) 26, 21 (24 m)
Death, BSID-III < 85, GMFCS 2-5
(school age)
Death, GMFCS 2-5, IQ < 85
Weeke score, grey matter subscore
Chang et al32 NR 107/120 11/80/16 18-24 29 BSID-III < 85 DWI lesion sizes and number
Bach et al18 4 [3,5] †††† 155/204 NR 30 NR BSID—II < 70 or BSID—III < 85 Barkovich score
Thoresen et al19 8 [6.5, 9] †††† 168/178 NR 18-24 21 Death, BSID-III < 85, GMFCS 3-5, SI, VI Rutherford score, WMxBGT
Steiner et al80 8 [4,9] †††† 54/56 0/45/11 24 25 Death, BSID-III < 70 NICHD NRN score, Rutherford score
Troha Gergeli et al81 5.7 ± 2.6 50/50 0/21/29 18, 60-72 37.8, 34 (18 m)
Death, BSID-III < 85
(60-72 m)
Death, moderately to severely abnormal ATNA, intractable epilepsy, GMFCS 2-5
Rutherford score
Aker et al82 5 ± 1 25/25 0/24/1 18 21 Death, BSID-III < 85,
GMFCS 3-5, VI, HI, seizures
Rutherford score

Mean ± SD if not specified.

††

Median (range).

†††

Range.

††††

Median [interquartile range].

*

Number of infants receiving hypothermia with neurodevelopmental follow-up and the total infants enrolled into this study.

**

Reported as mild, moderate, or severe.

Abbreviations: ADC = apparent diffusion coefficient, ATNA = Amiel-Tison Neurological Assessment, BSID-II = Bayley Scales of Infant Development II, BSID-III = Bayley Scales of Infant and Toddler Development third edition (Bayley-III), CP = cerebral palsy, GMDS = Griffiths mental developmental scales, GMFCS = Gross Motor Function Classification System, HI = hearing impairment, mIns = myo-inositol, NAA = N-acetylaspartate, NR = not reported, PLIC = posterior limb of internal capsule, VI = visual impairment.

Methods for grading and quantification of brain injury in HIE

Numerous qualitative and quantitative techniques are available for evaluating brain damage in MRI scans of neonates suffering from HIE. The primary imaging modality for discerning regions of brain injury in newborns with HIE combines conventional MRI methodologies, specifically T1-, T2-, and diffusion-weighted imaging (DWI).11,12 These established MRI techniques yield qualitative details, such as the locations and extent of brain lesions.11 Further, DWI facilitates early recognition of acute ischaemic injuries by measuring water molecule diffusion within brain tissue while providing quantifiable data through the apparent diffusion coefficient (ADC), which gives insights into the extracellular matrix.13 In addition, more sophisticated MRI techniques, including diffusion tensor imaging (DTI) and proton MR spectroscopy (1H-MRS), provide quantitative data on the brain’s microstructure and function.14

Brain injury patterns

The degree and location of brain injury in infants suffering from HIE can be categorized into three primary patterns. These classifications rely on the severity and duration of the hypoxic-ischaemic event, as well as the brain's level of maturation at the time of the event15 (Figures 1-4). It is important to recognize that neonatal brain injuries can manifest as a combination of injury patterns, and that these patterns and the severity of injuries can occasionally shift over time.16

Figure 1.

Figure 1.

Normal. MRI performed on day 4 in a newborn who received therapeutic hypothermia for HIE. The signal intensity of the posterior limb of the internal capsule appears normal on T1-weighted imaging (A), T2-weighted imaging (B) and diffusion-weighted imaging (C).

Figure 4.

Figure 4.

Near-total injury Pattern. MRI performed within the first week after birth, showing a near-total injury pattern characterized by extensive damage involving the cortex, white matter, basal ganglia, and thalami. These injured areas appear slightly hyperintense on T1-weighted imaging (A, B) and T2-weighted imaging (C, D) and are more easily visualized using diffusion weighted imaging (E, F).

Figure 2.

Figure 2.

BGT predominant Pattern. MRI performed within the first week after birth, showing injury involving bilateral posterior putamina and thalami (BGT) as well as bilateral optic radiations, which appear T1 hyperintense on T1-weighted (A) and T2-weighted imaging (B) and more evident on diffusion-weighted imaging (DWI) (C).

Figure 3.

Figure 3.

White matter/watershed predominant pattern. White matter/watershed predominant pattern. MRI performed on day 4 demonstrates a watershed predominant pattern of injury. T1-weighted inversion recovery imaging (A) and T2-weighted imaging (B) appear near completely normal with diffusion-weighted imaging (C) showing restricted diffusion in the watershed areas of frontoparietal lobes. Right frontoparietal scalp haematoma is also noted.

Basal ganglia and thalamus predominant pattern

The BGT pattern is often observed in circumstances that present a sudden disruption of placental perfusion or oxygen supply in the umbilical cord, which can arise due to placental abruption, umbilical cord prolapse, shoulder dystocia, or uterine rupture. This scenario typically results in acute, profound asphyxia, primarily affecting the ventrolateral thalami, posterior putamina, posterior limb of internal capsule (PLIC), and perirolandic cortex.

White matter/watershed predominant pattern

The white matter/watershed (WM/WS) pattern typically arises from mild to moderate asphyxia, also known as partial prolonged asphyxia, leading to a primary manifestation in the watershed areas. The lesions follow a parasagittal distribution along the vascular border zones and are also known as the “parasagittal pattern of injury”.

Near-total injury pattern

The Near Total Injury pattern, also labelled as “global injury”, characterizes infants subjected to very severe and prolonged asphyxia. This pattern is distinguished by widespread injury involving the entire or near entire hemispheres.17

Predicting LTNO based on injury patterns

Research studies have demonstrated that specific brain injury patterns, as well as MRI scoring systems, can effectively predict unfavourable neurodevelopmental outcomes in infants with HIE. Notably, the BGT injury pattern and near total injury pattern have been linked to adverse outcomes, while infants with only punctate white matter lesions did not exhibit a significantly increased risk.18–20 The BGT pattern has been associated with a higher risk of abnormal cognitive, motor, and composite neurocognitive outcomes than the WM/WS pattern at 2.5 years.18,21 On the contrary, the WM/WS pattern of injury has been associated with milder and fewer impacts on neurodevelopmental outcomes.22 Instances of the Near-Total Injury pattern are reported less frequently, often because these infants may be too medically unstable for scans after birth, and death may occur before an MRI can be performed.23

Quantitative diffusion imaging

Diffusion-weighted imaging and DTI are techniques for measuring diffusion-driven displacements of water molecules over time and probing the microstructural anomalies of the brain following an HIE event, affording quantitative detection of pathologies that are not discernible by conventional MRI. Both DWI and DTI can measure the mean diffusivity, while DTI provides a deeper characterization of water molecule movement, including fractional anisotropy (FA) as well as axial and radial diffusivity—longitudinal and transversal to the fibre direction, respectively.

Diffusion imaging is more sensitive, and the abnormalities can occur earlier—during the first hours to days—than conventional T1- and T2-weighted MRI after hypoxic ischaemic injury. The mean diffusivity or ADC is initially reduced, correlating with the severity of apoptotic injury.24 The mean coefficient reduction gradually recovers and reaches normal values (“pseudonormalization”) by the end of the first week following injury in normothermic patients, which can lead to underestimation of brain injury.25

One common analytic approach of diffusion imaging is the region of interest approach, wherein diffusion measures are collected from specified brain regions, determined either by manual delineation or automatic parcellation or segmentation. Multiple studies have noted that a lower ADC across various brain regions within the first week to 10 days is associated with adverse outcomes by using the region of interest approach.9 Beyond these, there are a few studies using more computationally demanding quantitative methods, including tract-based spatial statistics (TBSS) and a structural connectivity network approach. These methods are automated, observer-independent approaches that allow for robust comparisons of DTI without the need for subjective pre-specification of regions of interest.

Tract-based spatial statistics enables a comprehensive whole-brain analysis of aligned FA images derived from multi-subject diffusion data.26 Structural connectivity refers to the white matter tracts, or anatomical connections, between various brain regions. After these connections have been reconstructed, a connectivity matrix is established and examined using network analysis parameters. These include the node degree, clustering coefficient, and shortest path length, among other properties. However, while these analytic methods show promise, it is important to note that they are currently not standardized and often require advanced computation skills. As a result, their direct applicability in clinical practice remains limited currently.

Predicting LTNO based on diffusion imaging

Diffusion imaging, specifically ADC values in different brain structures, have been shown to predict adverse outcomes well. Multiple studies have noted that a lower ADC across various brain regions within the first week to 10 days is associated with adverse outcomes by using the region of interest approach.9 Key areas studied include the centrum semiovale, basal ganglia,27–30 thalami,28–31 and the PLIC.28–31 However, ADC values in the cerebellum and brainstem have not been associated with outcomes.31 Among the anatomic regions, the ADC values of PLIC (0.82 × 10−9/mm2/s30; 0.94 × 10−3/mm2/s31) was reported with the highest predictive value.30,31 The higher size and number of lesions on DWI are also associated with worse outcomes at 1.5-2 years, although the area under curve (AUC) did not surpass that of the NICHD score.32 The FA values of basal ganglia and PLIC are more specific but less sensitive than ADC values in predicting LTNO.9,33,34 Tusor et al utilized TBSS to illustrate significant associations between lower FA values in diverse brain regions and outcomes at the age of 2 years.35 Spencer et al used structural connectivity network approach to predict motor function in children aged 6-8 years, who were treated with TH and did not develop cerebral palsy.36

Proton MR spectroscopy

Proton nuclear magnetic resonance spectroscopy has the unique capability to discern metabolic changes and detect perturbations in neurochemistry instigated by perinatal asphyxia.37 Multiple studies have deployed 1H-MRS to forecast neurodevelopmental outcomes, utilizing a variety of metabolites and defining regions of interest.9,20,29,33,34,38–40 N-acetylaspartate (NAA) is the second most prevalent amino acid in the brain, found predominantly in neurons. It is widely recognized as a surrogate biomarker for neuronal integrity and function. Studies indicate that NAA levels tend to decrease following neuronal injury or dysfunction. Lactate, on the other hand, is a byproduct of anaerobic metabolism, so its levels increase in areas affected by hypoxic-ischaemic injuries. The lactate concentration associated with HIE fluctuates throughout the disease progression. In infants with moderate to severe HIE receiving TH, cerebral lactate concentrations are initially markedly elevated, show a slight decrease post-hypothermia, continue to decrease over time, and can still be detectable up to 2 weeks after birth.41 Conversely, lactate concentrations remain low in infants experiencing no or only mild HIE.41 The most common analytic approach involves using metabolite ratios in the basal ganglia and thalamus (BGT).29,34,38,39 The concentrations of metabolites in the other regions of grey matter and white matter have also been studied40 (Figure 5). Metabolite concentrations in newborns are age-dependent and vary from those in adults. Specifically, NAA and glutamate levels are lower during the neonatal period and rise during the first three months of life while myo-inositol levels fall. Beyond three months, these changes decelerate and tend to stabilize by around five years of age.42 Regarding the MRS acquisition techniques, single voxel and multi-voxel are the two main approaches. Single voxel MRS is the conventional choice for clinical MRS, allowing the acquisition of a single spectrum from a specific brain region in a relatively short time. Multi-voxel MRS, however, captures spectra from a larger tissue volume, providing the advantages of broader coverage and higher spatial resolution. However, multi-voxel MRS has the disadvantages of longer scan times and lower spectral quality due to less uniform shimming and lower signal-to-noise ratios in individual spectra.42 Currently, there is a lack of comparative studies evaluating the diagnostic accuracy between single voxel MRS versus multi-voxel MRS in neonatal HIE. In a large prospective multicenter study of infants who all underwent MRI and single voxel MRS in the first week of life, MRS was found to surpass structural MRI and DTI in predicting neurodevelopmental outcomes.34 However,1H-MRS is not without limitations: the necessity for predefining the investigative region could theoretically bypass injury in non-specified areas. Another constraint lies in its protracted acquisition time, although this can be mitigated by state-of-the-art imaging acceleration techniques.

Figure 5.

Figure 5.

Magnetic resonance spectroscopy (MRS). Two proton magnetic resonance spectroscopy (1H-MRS) studies were performed on the basal ganglia using an intermediate TE of 144 ms within the first week post hypoxic ischaemic encephalopathy in two infants. The first MRS from an infant with normal MRI findings (A) demonstrated a typical N-acetylaspartate (NAA) peak at 2.0 ppm, a creatine peak at 3.0 ppm, and a choline peak at 3.2 ppm. Conversely, the second MRS from an infant with near-total brain injury (B) showed a diminished NAA peak at 2.0 ppm and a lactate peak, which was observed as an inverted peak at 1.33 ppm.

Predicting LTNO based on 1H-MRS

Proton nuclear magnetic resonance spectroscopy has been shown to offer high sensitivity and specificity in predicting LTNO. However, it should be noted that the cut-off values depend on the parameters and scanners. In addition, some studies only performed group comparison without defining cut-off values. Several investigations have consistently found an association between the lactate/NAA ratio (>0.2234) or the (lactate + threonine)/NAA ratio (>0.3933) in the BGT and adverse outcomes.9,20,33,34 Additional metabolite ratios tied to negative neurodevelopmental outcomes include decreased NAA/Choline (≤1.82), NAA/Creatine (≤0.67), and myo-inositol (mln)/creatine (≤0.76) ratios in the BG,29 NAA concentration (≤5.6 mmol/kg wet weight),34 and mln/NAA ratios (≥0.6798) in the thalamus.38 In a prospective multicentre study of 223 infants, the NAA concentration in the thalamus(≤5.6 mmol/kg wet weight) alone had the highest predictive value of adverse neurocognitive outcome at a median age of 2 years [AUC, 0.99 (0.94-1.0)] compared to other metabolite ratios.34 While Barta et al, in another study of 51 subjects, compared various parameters of 1H-MRS at three echo-times and showed that mIns/NAA (≥0.6798) has the highest predictive value of adverse neurocognitive outcome (AUC, 0.9084; sensitivity: 84.62%, specificity: 95.24%),38 other metabolite ratios such as NAA/Cr at TE = 144 ms (<0.62738, ≤0.6729) NAA/Cho (≤ 1.8229), lactate/NAA,43 (lactate+lipids)/NAA (≥3.3329), mlns/creatine (>0.78038, ≤0.7629), and mIns/choline ratio (≤2.0429) have also shown predictive values for adverse outcomes.

Additional techniques

Fluid-attenuated inversion recovery imaging is useful at identifying hyperintensities within the periventricular and deep white matter and is capable of detecting cystic leukomalacia associated with advanced HIE damage. However, it may not offer additional prognostic value over other imaging sequences.12 Susceptibility-weighted imaging improves the detection of haemorrhages and calcifications. However, current research suggests that intracranial haemorrhages, despite being present in one-third of neonatal HIE cases, do not impact neurodevelopmental outcomes.44 Arterial Spin Labelling (ASL) offers a non-invasive approach to assess cerebral perfusion using magnetically labelled water protons as intrinsic tracers. Hyperperfusion in affected areas is commonly seen in the onset of neonatal HIE, regardless of whether hypothermia treatment is administered.45,46 Research with a small cohort (n = 28) indicates that increased perfusion in the BGT correlates with poor neurodevelopmental outcomes.47

MRI injury scoring systems

There are a multitude of MRI-based scoring systems which serve as valuable tools to quantify the degree of brain injury and forecast future outcomes in neonates with HIE. Some of the widely recognized scoring systems, including those proposed by Barkovich,48 National Institute of Child Health and Human Development (NICHD),17 and Rutherford,49 leverage T1-weighted and T2-weighted imaging to scrutinize cerebral injuries. These scoring systems pay particular attention to specific regions, namely, the BGT, posterior limb of the internal capsule (PLIC), white matter (WM), and cortical areas. Supplementing these conventional imaging techniques, Bednarek et al proposed a scoring system that underscores the significance of DWI and assigns a heavier weightage to injuries present in the deep grey matter nuclei and the posterior limb of the internal capsule.21,50 Weeke et al introduced a more comprehensive and intricate scoring system. This innovative approach combines the capabilities of traditional MRI techniques (including T1W, T2W, and DWI) with 1H-MRS, leading to a nuanced and robust grading system.51 An expanded NICHD NRN score has been proposed to separate WM/WS patterns and BGT/PLIC injuries and also incorporate the severity and laterality of lesions in the NICHD Optimizing Cooling Strategies trial. Unpublished preliminary results indicate promising results in predicting LTNO.52,53  Table 2 provides a detailed and comparative summary of different MR scoring systems.

Table 2.

Comparative Summary of MRI scoring systems.

Scores Barkovich score Rutherford score NICHD NRN Score Injury Score Weeke Score
Area assessed BGT, watershed (WM and cortex) BGT, PLIC, WM, cortex BGT, ALIC, PLIC, watershed BG, WM, Cortex, cerebellum, brainstem GM, WM, cerebellum,
1H-MRS of BG, IVH, SDH, CVST
Descriptions and characteristics Categorizes injuries into BGT, watershed areas, a combination of both, and the total extent of injury
  1. Includes PLIC injury as a distinct category, separate from BGT injury.

  2. No total score

  1. Integrates ALIC and PLIC injuries under the category of BGT injury.

  2. BGT injury is classified as more severe than WM injury

  1. Encompasses infratentorial structures, including the brainstem and cerebellum.

  2. Quantify T1W, T2W, and DWI independently for each hemisphere

  1. Includes infratentorial structures.

  2. More detailed subscores

  3. Integrates findings from structural MRI, MRS, intracranial haemorrhages, and CVST

Levels 5 (0-4) BGT (0-3), PLIC (0-2), WM (0-3), GM (0-3) 6 (0,1A&B, 2A&B, 3) 139 (48-186) 56 (0-55)
Reference Barkovich et al48 Rutherford et al11 Shankaran et al17 Bednarek et al50 Weeke et al51

Abbreviations: ALIC = anterior limb of internal capsule, BGT = basal ganglia and thalamus, CVST = cerebral venous sinus thrombosis, DWI = Diffusion-weighted imaging, IVH = intraventricular haemorrhage, MRS = Magnetic Resonance Spectroscopy, NAA = N-Acetylaspartate, PLIC = posterior limb of internal capsule, SDH = subdural haemorrhage, T1W = T1-weighted imaging, T2W = T2-weighted imaging, WM = white matter.

Predicting LTNO based on injury scores

Multiple research studies have affirmed the close association between MRI injury scores, such as NICHD, Barkovich, Rutherford, Weeke, and Trivedi scores, and subsequent unfavourable neurodevelopmental outcomes after TH treatment.19,21,43,51,54,55 Notably, a comparative study scrutinizing the Barkovich, NICHD, and Weeke scoring systems found that all three systems provided reliable predictive values for cognitive and motor outcomes in HIE-affected infants at the age of two years. However, only the Weeke scoring system was significantly linked with language development scores at the same age.56 A novel metric, WMxBGT, proposed by Thoresen et al. was proposed to be more predictive of adverse neurocognitive development than the total injury score.19

Long-term epilepsy outcomes in HIE

Perinatal Hypoxic-Ischaemic Encephalopathy (HIE) is a major precursor to neurological repercussions such as epilepsy. In newborns affected by HIE, neonatal seizures emerge as a common manifestation, with prevalence approximating 75%.57,58 Notably, More than two-thirds of neonates with HIE have self-limiting seizures in the neonatal period and do not develop postneonatal epilepsy.59–64 These seizures manifest in diverse forms, including infantile spasms, focal seizures, and generalized seizures.65 TH has been purported to reduce the incidence of epilepsy subsequent to HIE.66–68 However, a study contested this notion, indicating no discernible difference in epilepsy incidence between infants undergoing TH and those not undergoing this treatment.58

MRI predictors of epilepsy outcome in HIE

The incidence of postneonatal epilepsy was low (<3%) in cases with either normal MRI or isolated cortical injuries.58,62 Both the watershed and BGT injury patterns were associated with increased odds of epilepsy in later childhood, with the latter exhibiting a significantly higher risk.58,62,65,69 In fact, over a third of newborns with the BGT injury pattern developed postneonatal epilepsy. Infants who survived brainstem and total injury were at the highest risk of developing infantile spasms, although a significant percentage of newborns did not survive these severe injuries.62,69 These associations between injury patterns and the incidences of postneonatal epilepsy were not influenced by hypothermia treatment.58 Injuries to specific brain regions, including the hippocampi, motor cortices, and occipital lobes, are also associated with an increased epilepsy risk. However, when adjusting for the prevailing watershed and basal ganglia injury patterns, these associations were no longer significant.58 Coexisting MRI abnormalities indicative of hypoglycemic injury, such as abnormal signals involving the posterior white matter, optic radiations and pulvinars, were associated with a heightened risk of neonatal seizures, although they did not predict epilepsy in later childhood.58,67

Effect of TH on imaging appearance

TH has demonstrated a positive trend in increasing the number of normal scans in infants following HIE. Moreover, it was shown to reduce the extent of infarction in infants with abnormal MRIs when compared to infants in the control group.11,17 TH can impact the evolution of diffusion abnormalities. Infants treated with hypothermia demonstrate a phenomenon known as pseudonormalization of DWI at a later stage, typically around the 10th day of life, in contrast to untreated infants who exhibit this phenomenon between days 6 and 8.50 Additionally, hypothermia has been observed to modify diffusion characteristics.70 Furthermore, TH has been found to significantly influence metabolite concentrations across different brain regions. This includes increased energy reserves, such as phosphocreatine and free creatine concentrations, as well as decreased levels of excitatory neurotransmitters and cellular energy demand, such as glutamate, glutamine, GABA, and aspartate concentrations, when compared to metabolite levels after rewarming.71 Despite these alterations, recent analyses suggest that hypothermia treatment does not impact the prognostic value of MRI.9

Optimal timing of MRI

Recent evidence highlights the effectiveness of MRI within the first two weeks after birth as a reliable prognostic tool, potentially surpassing other neurophysiological evaluations like continuous video electroencephalography (EEG) and amplitude-integrated EEG in predicting long-term neurological outcomes.7 However, the optimal timing for MRI examination remains a subject of debate. The draft framework proposed by the British Association of Perinatal Medicine (BAPM) suggests that MRI should be conducted within the first 4-14 days of life and that early imaging (<6 days) has demonstrated the ability to accurately detect injuries.12 In the 2nd edition of guidelines of Neonatal Encephalopathy and Neurologic Outcome (reaffirmed in 2019) published by the American College of Obstetrics and Gynecology and the American Academy of Pediatrics, a two-phase MRI approach is proposed for neonates undergoing TH. An early MRI (24-96 h) helps determine the injury onset, while a subsequent MRI (7-21 days) reveals the full extent of the injury.72 However, obtaining an early MRI within 24-96 h may not be feasible for patients undergoing TH during the initial 72 h. Studies comparing early (≤6 days) and late MRI (≥7 days) scans indicate that both have high sensitivity (100% in identifying unfavourable outcomes, but early MRI demonstrates higher specificity (96.3% vs. 89.3%)) due to its ability to detect mild abnormalities missed by later scans.30 In the Total Body Hypothermia for Neonatal Encephalopathy (TOBY) trial, early MRIs (<8 days) were more effective at identifying major abnormalities compared to later scans (63% vs. 47% of cases).1 A variety of MRI injury scores show significant agreement between early and late MRI (75%-88%), with early MRI exhibiting superior predictive value for adverse outcomes.16,21,73 Two studies reported the MRI injury scores increased in 57%-66% of late MRI, and one reported decrease in 58% of late MRIs.16,21,73 Meta-analyses indicate that early MRI (the first week) scores have better sensitivity, specificity, and diagnostic odds ratio values compared to later MRI (the second week) scans.9 Early MRI also prevents pseudonormalization of mean diffusivity observed on day 9 in cooled neonates.50 Overall, these findings support the use of early MRI for prognosticating neonatal HIE.

HIE mimics

In addition to HIE, a variety of clinical conditions, such as vascular anomalies, perinatal stroke, metabolic diseases, infections, or congenital abnormalities, can lead to neonatal encephalopathy. It is crucial to recognize distinct patterns and severity in neuroimaging to determine the underlying cause. Neurometabolic disorders are rare but significant contributors to paediatric brain conditions and can mimic HIE in imaging. It should be considered in the differential diagnosis of HIE when the clinical presentation is ambiguous. The most common inherited metabolic disorders during the neonatal stage are mitochondrial diseases, urea cycle disorders, and organic acidemias.74 Leigh syndrome, a most common neonatal-onset mitochondrial disease,75 typically presents with bilateral symmetrical T2 hyperintensities in the basal ganglia, especially in the putamen and caudate nucleus.76 Other susceptible areas include the thalamus, brainstem, medulla oblongata, cerebellum, and spinal cord.76 Neonatal-onset organic acidemias are varied in imaging presentations and usually display symmetrical brain disease, impacting the bilateral cortex, white matter, or basal ganglia.77

In neonatal-onset urea cycle disorders, two main neuroimaging patterns are recognized: diffuse and central. The diffuse pattern is the more severe form, widely involving the cerebral cortex and basal ganglia, and may occasionally affect the thalami and brainstem, which can make it challenging to distinguish from HIE.78 Conversely, the central pattern is more specific to urea cycle disorders, characterized by symmetric edema—whether vasogenic, cytotoxic, or intramyelinic—typically located in the insular/periinsular, sylvian/perisylvian, perirolandic, and basal ganglia regions. A notable characteristic that differentiates it from HIE is the thalami typically remaining unaffected.78

Conclusions and future directions

Brain MRI, which incorporates DWI, is considered the benchmark for evaluating brain injury in infants suffering from HIE. The patterns and scope of injury provide vital information about the timing and intensity of the hypoxic-ischaemic event, aiding in forecasting possible neurodevelopmental outcomes. BGT predominant and Near-total injury patterns are linked with the unfavourable LTNO and an increased likelihood of postneonatal epilepsy. An accurate characterization of these patterns is essential for providing valuable prognostic information. Several MRI scoring systems have been instituted to quantify brain injury using neonatal MRI. These methodologies have proven effective in predicting the neurodevelopmental outcomes of infants affected by HIE. 1H-MRS has been shown to offer high predictive values in prognosticating newborns with HIE by providing crucial metabolic data.33,34 However, the techniques and metabolite ratios involved in 1H-MRS are not yet standardized. The methods for predicting LTNO using MRI are summarized in Table 3.

Table 3.

Overview of approaches to predict long-term neurodevelopmental outcomes using MRI.

Approaches Predictors associated with unfavourable long-term neurodevelopmental outcome
Brain Injury Pattern
  • BGT pattern, near total injury pattern

Quantitative diffusion Imaging
  • Lower ADC values of several anatomic regions, such as centrum semiovale, BGT, PLIC

  • The ADC values of PLIC have been reported to have the highest predictive value

Proton MRS
  • Various metabolite ratios, such as lactate/NAA, NAA/Cr, and NAA/Cho.

  • The NAA concentration of thalamus and mlns/NAA ratio have been reported to have the highest predictive values

ASL
  • Increased perfusion in the BGT region

injury Score
  • The details of the most commonly used injury scoring systems are presented in Table 2.

  • Higher scores correlate with less favourable outcomes.

Abbreviations: ADC = apparent diffusion coefficient, ASL = arterial spin labelling, BGT = basal ganglia and thalamus, Cho = choline, Cr = creatine, mln = myoinositol, MRS = magnetic resonance spectroscopy, NAA = N-Acetylaspartate, PLIC = posterior limb of internal capsule.

In terms of timing of imaging, it is considered optimal to conduct the MRI, including DWI and 1H-MRS, immediately following TH, typically within the first week after birth. This is due to the peak of diffusion abnormalities occurring between 3 and 5 days post birth, with pseudonormalization of both DWI and 1H-MRS occurring by the end of the first week.

Despite these advances, using MRI for outcome prediction in HIE is not without challenges. MRI interpretation can be subjective, and the application of previous research is often limited by the relatively small subject numbers and the heterogenenity of severity of the disease among subjects. This is compounded by differences in the percentages of various grades of encephalopathy and adverse outcomes in research.

Future studies could potentially address these limitations through multi-site studies and the application of advanced AI algorithms, which could offer a more objective and accurate interpretation of MR images.79 The integration of MRI findings with other biomarkers and clinical data could also further enhance the accuracy of outcome prediction.

Contributor Information

Sheng-Che Hung, Department of Radiology, School of Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, United States.

Yi-Fang Tu, Department of Pediatrics, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan 70403, Taiwan.

Senyene E Hunter, Department of Neurology, School of Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC 27599-7025, United States.

Carolina Guimaraes, Department of Radiology, School of Medicine, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, United States.

Funding

None declared.

Conflict of interest

The authors have no conflict of interest.

References

  • 1. Douglas-Escobar M, Weiss MD.  Hypoxic-ischemic encephalopathy: a review for the clinician. JAMA Pediatr. 2015;169(4):397-403. 10.1001/jamapediatrics.2014.3269 [DOI] [PubMed] [Google Scholar]
  • 2. Azzopardi D, Strohm B, Marlow N, et al.  Effects of hypothermia for perinatal asphyxia on childhood outcomes. N Engl J Med. 2014;371(2):140-149. 10.1056/NEJMoa1315788 [DOI] [PubMed] [Google Scholar]
  • 3. Simbruner G, Mittal RA, Rohlmann F, Muche R, Neo.nEURO.network Trial Participants. Systemic hypothermia after neonatal encephalopathy: outcomes of neo.nEURO.network RCT. Pediatrics. 2010;126(4):e771-8. 10.1542/peds.2009-2441 [DOI] [PubMed] [Google Scholar]
  • 4. Jacobs SE, Morley CJ, Inder TE, et al.  Whole-body hypothermia for term and near-term newborns with hypoxic-ischemic encephalopathy: a randomized controlled trial. Arch Pediatr Adolesc Med. 2011;165(8):692-700. 10.1001/archpediatrics.2011.43 [DOI] [PubMed] [Google Scholar]
  • 5. Shankaran S, Laptook AR, Ehrenkranz RA, et al.  Whole-body hypothermia for neonates with hypoxic-ischemic encephalopathy. N Engl J Med. 2005;353(15):1574-1584. 10.1056/NEJMcps050929 [DOI] [PubMed] [Google Scholar]
  • 6. Martinello K, Hart AR, Yap S, Mitra S, Robertson NJ.  Management and investigation of neonatal encephalopathy: 2017 update. Arch Dis Child Fetal Neonatal Ed. 2017;102(4):F346-F358. 10.1136/archdischild-2015-309639 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7. Liu W, Yang Q, Wei H, Dong W, Fan Y, Hua Z.  prognostic value of clinical tests in neonates with hypoxic-ischemic encephalopathy treated with therapeutic hypothermia: a systematic review and meta-analysis. Front Neurol. 2020;11:133. 10.3389/fneur.2020.00133 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8. Sánchez Fernández I, Morales-Quezada JL, Law S, Kim P.  Prognostic Value of Brain Magnetic Resonance Imaging in Neonatal Hypoxic-Ischemic Encephalopathy: A Meta-analysis. J Child Neurol. 2017;32(13):1065-1073. 10.1177/0883073817726681 [DOI] [PubMed] [Google Scholar]
  • 9. Ouwehand S, Smidt LCA, Dudink J, et al.  Predictors of outcomes in hypoxic-ischemic encephalopathy following hypothermia: a meta-analysis. Neonatology. 2020;117(4):411-427. 10.1159/000505519 [DOI] [PubMed] [Google Scholar]
  • 10. van Handel M, Swaab H, de Vries LS, Jongmans MJ.  Long-term cognitive and behavioral consequences of neonatal encephalopathy following perinatal asphyxia: a review. Eur J Pediatr. 2007;166(7):645-654. 10.1007/s00431-007-0437-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11. Rutherford M, Ramenghi LA, Edwards AD, et al.  Assessment of brain tissue injury after moderate hypothermia in neonates with hypoxic-ischaemic encephalopathy: a nested substudy of a randomised controlled trial. Lancet Neurol. 2010;9(1):39-45. 10.1016/S1474-4422(09)70295-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.DRAFT Framework: Neonatal Brain Magnetic Resonance Imaging | British Association of Perinatal Medicine. DRAFT Framework: Neonatal Brain Magnetic Resonance Imaging. January 23, 2023. Accessed November 25, 2023. https://www.bapm.org/resources/neonatal-brain-magnetic-resonance-imaging
  • 13. Schaefer PW, Grant PE, Gonzalez RG.  Diffusion-weighted MR imaging of the brain. Radiology. 2000;217(2):331-345. 10.1148/radiology.217.2.r00nv24331 [DOI] [PubMed] [Google Scholar]
  • 14. Liu Y, Aeby A, Balériaux D, et al.  White matter abnormalities are related to microstructural changes in preterm neonates at term-equivalent age: a diffusion tensor imaging and probabilistic tractography study. AJNR Am J Neuroradiol. 2012;33(5):839-845. 10.3174/ajnr.A2872 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Gunn AJ, Bennet L.  Fetal hypoxia insults and patterns of brain injury: insights from animal models. Clin Perinatol. 2009;36(3):579-593. 10.1016/j.clp.2009.06.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Chakkarapani E, Poskitt KJ, Miller SP, et al.  Reliability of early magnetic resonance imaging (MRI) and necessity of repeating MRI in noncooled and cooled infants with neonatal encephalopathy. J Child Neurol. 2016;31(5):553-559. 10.1177/0883073815600865 [DOI] [PubMed] [Google Scholar]
  • 17. Shankaran S, Barnes PD, Hintz SR, et al.  Brain injury following trial of hypothermia for neonatal hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed. 2012;97(6):F398-404. 10.1136/archdischild-2011-301524 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Bach AM, Fang AY, Bonifacio S, et al.  Early magnetic resonance imaging predicts 30-month outcomes after therapeutic hypothermia for neonatal encephalopathy. J Pediatr. 2021;238:94-101.e1. 10.1016/j.jpeds.2021.07.003 [DOI] [PubMed] [Google Scholar]
  • 19. Thoresen M, Jary S, Walløe L, et al.  MRI combined with early clinical variables are excellent outcome predictors for newborn infants undergoing therapeutic hypothermia after perinatal asphyxia. EClinicalMedicine. 2021;36:100885. 10.1016/j.eclinm.2021.100885 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Wu YW, Monsell SE, Glass HC, et al.  How well does neonatal neuroimaging correlate with neurodevelopmental outcomes in infants with hypoxic-ischemic encephalopathy?  Pediatr Res. 2023;94(3):1018-1025. 10.1038/s41390-023-02510-8 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 21. Trivedi SB, Vesoulis ZA, Rao R, et al.  A validated clinical MRI injury scoring system in neonatal hypoxic-ischemic encephalopathy. Pediatr Radiol. 2017;47(11):1491-1499. 10.1007/s00247-017-3893-y [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. de Vries LS, Jongmans MJ.  Long-term outcome after neonatal hypoxic-ischaemic encephalopathy. Arch Dis Child Fetal Neonatal Ed. 2010;95(3):F220-4. 10.1136/adc.2008.148205 [DOI] [PubMed] [Google Scholar]
  • 23. Miller SP, Ramaswamy V, Michelson D, et al.  Patterns of brain injury in term neonatal encephalopathy. J Pediatr. 2005;146(4):453-460. 10.1016/j.jpeds.2004.12.026 [DOI] [PubMed] [Google Scholar]
  • 24. Wendland MF, Faustino J, West T, Manabat C, Holtzman DM, Vexler ZS.  Early diffusion-weighted MRI as a predictor of caspase-3 activation after hypoxic-ischemic insult in neonatal rodents. Stroke. 2008;39(6):1862-1868. 10.1161/STROKEAHA.107.506352 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25. Hayakawa K, Koshino S, Tanda K, et al.  Diffusion pseudonormalization and clinical outcome in term neonates with hypoxic-ischemic encephalopathy. Pediatr Radiol. 2018;48(6):865-874. 10.1007/s00247-018-4094-z [DOI] [PubMed] [Google Scholar]
  • 26. Smith SM, Jenkinson M, Johansen-Berg H, et al.  Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage. 2006;31(4):1487-1505. 10.1016/j.neuroimage.2006.02.024 [DOI] [PubMed] [Google Scholar]
  • 27. Alderliesten T, de Vries LS, Staats L, et al.  MRI and spectroscopy in (near) term neonates with perinatal asphyxia and therapeutic hypothermia. Arch Dis Child Fetal Neonatal Ed. 2017;102(2):F147-F152. 10.1136/archdischild-2016-310514 [DOI] [PubMed] [Google Scholar]
  • 28. Al Amrani F, Kwan S, Gilbert G, Saint-Martin C, Shevell M, Wintermark P.  Early imaging and adverse neurodevelopmental outcome in asphyxiated newborns treated with hypothermia. Pediatr Neurol. 2017;73:20-27. 10.1016/j.pediatrneurol.2017.04.025 [DOI] [PubMed] [Google Scholar]
  • 29. Ancora G, Testa C, Grandi S, et al.  Prognostic value of brain proton MR spectroscopy and diffusion tensor imaging in newborns with hypoxic-ischemic encephalopathy treated by brain cooling. Neuroradiology. 2013;55(8):1017-1025. 10.1007/s00234-013-1202-5 [DOI] [PubMed] [Google Scholar]
  • 30. Charon V, Proisy M, Bretaudeau G, et al.  Early MRI in neonatal hypoxic-ischaemic encephalopathy treated with hypothermia: Prognostic role at 2-year follow-up. Eur J Radiol. 2016;85(8):1366-1374. 10.1016/j.ejrad.2016.05.005 [DOI] [PubMed] [Google Scholar]
  • 31. Heursen E-M, Zuazo Ojeda A, Benavente Fernández I, et al.  Prognostic value of the apparent diffusion coefficient in newborns with hypoxic-ischaemic encephalopathy treated with therapeutic hypothermia. Neonatology. 2017;112(1):67-72. 10.1159/000456707 [DOI] [PubMed] [Google Scholar]
  • 32. Chang PD, Chow DS, Alber A, Lin Y-K, Youn YA.  Predictive values of location and volumetric MRI injury patterns for neurodevelopmental outcomes in hypoxic-ischemic encephalopathy neonates. Brain Sci. 2020;10(12). 10.3390/brainsci10120991 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Mitra S, Kendall GS, Bainbridge A, et al.  Proton magnetic resonance spectroscopy lactate/N-acetylaspartate within 2 weeks of birth accurately predicts 2-year motor, cognitive and language outcomes in neonatal encephalopathy after therapeutic hypothermia. Arch Dis Child Fetal Neonatal Ed. 2019;104(4):F424-F432. 10.1136/archdischild-2018-315478 [DOI] [PubMed] [Google Scholar]
  • 34. Lally PJ, Montaldo P, Oliveira V, et al.  Magnetic resonance spectroscopy assessment of brain injury after moderate hypothermia in neonatal encephalopathy: a prospective multicentre cohort study. Lancet Neurol. 2019;18(1):35-45. 10.1016/S1474-4422(18)30325-9 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Tusor N, Wusthoff C, Smee N, et al.  Prediction of neurodevelopmental outcome after hypoxic-ischemic encephalopathy treated with hypothermia by diffusion tensor imaging analyzed using tract-based spatial statistics. Pediatr Res. 2012;72(1):63-69. 10.1038/pr.2012.40 [DOI] [PubMed] [Google Scholar]
  • 36. Spencer APC, Brooks JCW, Masuda N, et al.  Motor function and white matter connectivity in children cooled for neonatal encephalopathy. Neuroimage Clin. 2021;32:102872. 10.1016/j.nicl.2021.102872 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Peden CJ, Cowan FM, Bryant DJ, et al.  Proton MR spectroscopy of the brain in infants. J Comput Assist Tomogr. 1990;14(6):886-894. 10.1097/00004728-199011000-00004 [DOI] [PubMed] [Google Scholar]
  • 38. Barta H, Jermendy A, Kolossvary M, et al.  Prognostic value of early, conventional proton magnetic resonance spectroscopy in cooled asphyxiated infants. BMC Pediatr. 2018;18(1):302. 10.1186/s12887-018-1269-6 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Alderliesten T, de Vries LS, Khalil Y, et al.  Therapeutic hypothermia modifies perinatal asphyxia-induced changes of the corpus callosum and outcome in neonates. PLoS One. 2015;10(4):e0123230. 10.1371/journal.pone.0123230 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Sijens PE, Wischniowsky K, Ter Horst HJ.  The prognostic value of proton magnetic resonance spectroscopy in term newborns treated with therapeutic hypothermia following asphyxia. Magn Reson Imaging. 2017;42:82-87. 10.1016/j.mri.2017.06.001 [DOI] [PubMed] [Google Scholar]
  • 41. Wu T-W, Tamrazi B, Hsu K-H, et al.  Cerebral lactate concentration in neonatal hypoxic-ischemic encephalopathy: in relation to time, characteristic of injury, and serum lactate concentration. Front Neurol. 2018;9:293. 10.3389/fneur.2018.00293 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42. Blüml S, Saunders A, Tamrazi B.  Proton MR spectroscopy of pediatric brain disorders. Diagnostics (Basel). 2022;12(6):1462. 10.3390/diagnostics12061462 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. Brocard C, Belaroussi Y, Labat J, Delmas J, Brissaud O, Chateil J-F.  Brain MRI after therapeutic hypothermia in asphyxiated newborns: Predictive value at one year of imaging features. Eur J Radiol. 2021;139:109724. 10.1016/j.ejrad.2021.109724 [DOI] [PubMed] [Google Scholar]
  • 44. Lakatos A, Kolossváry M, Szabó M, et al.  Neurodevelopmental effect of intracranial hemorrhage observed in hypoxic ischemic brain injury in hypothermia-treated asphyxiated neonates—an MRI study. BMC Pediatr. 2019;19(1):430. 10.1186/s12887-019-1777-z [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45. Wintermark P, Hansen A, Gregas MC, et al.  Brain perfusion in asphyxiated newborns treated with therapeutic hypothermia. AJNR Am J Neuroradiol. 2011;32(11):2023-2029. 10.3174/ajnr.A2708 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Meng L, Wang Q, Li Y, Ma X, Li W, Wang Q.  Diagnostic performance of arterial spin-labeled perfusion imaging and diffusion-weighted imaging in full-term neonatal hypoxic-ischemic encephalopathy. J Integr Neurosci. 2021;20(4):985-991. 10.31083/j.jin2004099 [DOI] [PubMed] [Google Scholar]
  • 47. De Vis JB, Hendrikse J, Petersen ET, et al.  Arterial spin-labelling perfusion MRI and outcome in neonates with hypoxic-ischemic encephalopathy. Eur Radiol. 2015;25(1):113-121. 10.1007/s00330-014-3352-1 [DOI] [PubMed] [Google Scholar]
  • 48. Barkovich AJ, Hajnal BL, Vigneron D, et al.  Prediction of neuromotor outcome in perinatal asphyxia: evaluation of MR scoring systems. AJNR Am J Neuroradiol. 1998;19(1):143-149. [PMC free article] [PubMed] [Google Scholar]
  • 49. Rutherford MA, Pennock JM, Counsell SJ, et al.  Abnormal magnetic resonance signal in the internal capsule predicts poor neurodevelopmental outcome in infants with hypoxic-ischemic encephalopathy. Pediatrics. 1998;102(2 Pt 1):323-328. 10.1542/peds.102.2.323 [DOI] [PubMed] [Google Scholar]
  • 50. Bednarek N, Mathur A, Inder T, Wilkinson J, Neil J, Shimony J.  Impact of therapeutic hypothermia on MRI diffusion changes in neonatal encephalopathy. Neurology. 2012;78(18):1420-1427. 10.1212/WNL.0b013e318253d589 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51. Weeke LC, Groenendaal F, Mudigonda K, et al.  A novel magnetic resonance imaging score predicts neurodevelopmental outcome after perinatal asphyxia and therapeutic hypothermia. J Pediatr. 2018;192:33-40.e2. 10.1016/j.jpeds.2017.09.043 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Shankaran S, Laptook AR, Pappas A, et al.  Effect of depth and duration of cooling on death or disability at age 18 months among neonates with hypoxic-ischemic encephalopathy: a randomized clinical trial. JAMA. 2017;318(1):57-67. 10.1001/jama.2017.7218 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 53. Shankaran S, Laptook A, Guimaraes CV, Murnick J, McDonald SA. Magnetic resonance imaging (MRI) in term infants with hypoxic-ischemic encephalopathy (HIE) in the optimizing Cooling strategies trial. 2023. Accessed July 28, 2023. https://2023.pas-meeting.org/index.asp?presTarget=2348509
  • 54. Shankaran S, McDonald SA, Laptook AR, et al.  Neonatal magnetic resonance imaging pattern of brain injury as a biomarker of childhood outcomes following a trial of hypothermia for neonatal hypoxic-ischemic encephalopathy. J Pediatr. 2015;167(5):987-993.e3. 10.1016/j.jpeds.2015.08.013 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Weeke LC, Boylan GB, Pressler RM, et al.  Role of EEG background activity, seizure burden and MRI in predicting neurodevelopmental outcome in full-term infants with hypoxic-ischaemic encephalopathy in the era of therapeutic hypothermia. Eur J Paediatr Neurol. 2016;20(6):855-864. 10.1016/j.ejpn.2016.06.003 [DOI] [PubMed] [Google Scholar]
  • 56. Ní Bhroin M, Kelly L, Sweetman D, et al.  Relationship between MRI scoring systems and neurodevelopmental outcome at two years in infants with neonatal encephalopathy. Pediatr Neurol. 2022;126:35-42. 10.1016/j.pediatrneurol.2021.10.005 [DOI] [PubMed] [Google Scholar]
  • 57. Lin Y-K, Hwang-Bo S, Seo Y-M, Youn Y-A.  Clinical seizures and unfavorable brain MRI patterns in neonates with hypoxic ischemic encephalopathy. Medicine (Baltimore)  2021;100(12):e25118. 10.1097/MD.0000000000025118 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Xu Q, Chau V, Sanguansermsri C, et al.  Pattern of brain injury predicts long-term epilepsy following neonatal encephalopathy. J Child Neurol. 2019;34(4):199-209. 10.1177/0883073818822361 [DOI] [PubMed] [Google Scholar]
  • 59. Pisani F, Orsini M, Braibanti S, Copioli C, Sisti L, Turco EC.  Development of epilepsy in newborns with moderate hypoxic-ischemic encephalopathy and neonatal seizures. Brain Dev. 2009;31(1):64-68. 10.1016/j.braindev.2008.04.001 [DOI] [PubMed] [Google Scholar]
  • 60. Belet N, Belet U, Incesu L, et al.  Hypoxic-ischemic encephalopathy: correlation of serial MRI and outcome. Pediatr Neurol. 2004;31(4):267-274. 10.1016/j.pediatrneurol.2004.04.011 [DOI] [PubMed] [Google Scholar]
  • 61. van Kooij BJM, van Handel M, Nievelstein RAJ, Groenendaal F, Jongmans MJ, de Vries LS.  Serial MRI and neurodevelopmental outcome in 9- to 10-year-old children with neonatal encephalopathy. J Pediatr. 2010;157(2):221-227.e2. 10.1016/j.jpeds.2010.02.016 [DOI] [PubMed] [Google Scholar]
  • 62. Jung DE, Ritacco DG, Nordli DR, Koh S, Venkatesan C.  Early anatomical injury patterns predict epilepsy in head cooled neonates with hypoxic-ischemic encephalopathy. Pediatr Neurol. 2015;53(2):135-140. 10.1016/j.pediatrneurol.2015.04.009 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63. Shellhaas RA, Wusthoff CJ, Numis AL, et al.  Early-life epilepsy after acute symptomatic neonatal seizures: A prospective multicenter study. Epilepsia. 2021;62(8):1871-1882. 10.1111/epi.16978 [DOI] [PubMed] [Google Scholar]
  • 64. Glass HC, Soul JS, Chang T, et al.  Safety of early discontinuation of antiseizure medication after acute symptomatic neonatal seizures. JAMA Neurol. 2021;78(7):817-825. 10.1001/jamaneurol.2021.1437 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65. McDonough TL, Paolicchi JM, Heier LA, et al.  Prediction of future epilepsy in neonates with hypoxic-ischemic encephalopathy who received selective head cooling. J Child Neurol. 2017;32(7):630-637. 10.1177/0883073817698628 [DOI] [PubMed] [Google Scholar]
  • 66. Harbert MJ, Tam EWY, Glass HC, et al.  Hypothermia is correlated with seizure absence in perinatal stroke. J Child Neurol. 2011;26(9):1126-1130. 10.1177/0883073811408092 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Inoue T, Shimizu M, Hamano S-I, Murakami N, Nagai T, Sakuta R.  Epilepsy and West syndrome in neonates with hypoxic-ischemic encephalopathy. Pediatr Int. 2014;56(3):369-372. 10.1111/ped.12257 [DOI] [PubMed] [Google Scholar]
  • 68. Liu X, Jary S, Cowan F, Thoresen M.  Reduced infancy and childhood epilepsy following hypothermia-treated neonatal encephalopathy. Epilepsia. 2017;58(11):1902-1911. 10.1111/epi.13914 [DOI] [PubMed] [Google Scholar]
  • 69. Gano D, Sargent MA, Miller SP, et al.  MRI findings in infants with infantile spasms after neonatal hypoxic-ischemic encephalopathy. Pediatr Neurol. 2013;49(6):401-405. 10.1016/j.pediatrneurol.2013.08.007 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Gano D, Chau V, Poskitt KJ, et al.  Evolution of pattern of injury and quantitative MRI on days 1 and 3 in term newborns with hypoxic-ischemic encephalopathy. Pediatr Res. 2013;74(1):82-87. 10.1038/pr.2013.69 [DOI] [PubMed] [Google Scholar]
  • 71. Wisnowski JL, Wu T-W, Reitman AJ, et al.  The effects of therapeutic hypothermia on cerebral metabolism in neonates with hypoxic-ischemic encephalopathy: An in vivo 1H-MR spectroscopy study. J Cereb Blood Flow Metab. 2016;36(6):1075-1086. 10.1177/0271678X15607881 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Executive summary: Neonatal encephalopathy and neurologic outcome, second edition. Report of the American College of Obstetricians and Gynecologists’ Task Force on Neonatal Encephalopathy. Obstet Gynecol. 2014;123(4):896-901. 10.1097/01.AOG.0000445580.65983.d2 [DOI] [PubMed] [Google Scholar]
  • 73. O'Kane A, Vezina G, Chang T, et al.  Early versus late brain magnetic resonance imaging after neonatal hypoxic ischemic encephalopathy treated with therapeutic hypothermia. J Pediatr. 2021;232:73-79.e2. 10.1016/j.jpeds.2021.01.050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Koç Yekedüz M, Şen Akova B, Köse E, et al.  Early neuroimaging findings of infants diagnosed with inherited metabolic disorders in neonatal period: A case-control study. Clin Neurol Neurosurg. 2022;222:107474. 10.1016/j.clineuro.2022.107474 [DOI] [PubMed] [Google Scholar]
  • 75. Ebihara T, Nagatomo T, Sugiyama Y, et al.  Neonatal-onset mitochondrial disease: clinical features, molecular diagnosis and prognosis. Arch Dis Child Fetal Neonatal Ed. 2022;107(3):329-334. 10.1136/archdischild-2021-321633 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Baertling F, Klee D, Haack TB, et al.  The many faces of paediatric mitochondrial disease on neuroimaging. Childs Nerv Syst. 2016;32(11):2077-2083. 10.1007/s00381-016-3190-3 [DOI] [PubMed] [Google Scholar]
  • 77. Reddy N, Calloni SF, Vernon HJ, Boltshauser E, Huisman TAGM, Soares BP.  Neuroimaging findings of organic acidemias and aminoacidopathies. Radiographics. 2018;38(3):912-931. 10.1148/rg.2018170042 [DOI] [PubMed] [Google Scholar]
  • 78. Sen K, Anderson AA, Whitehead MT, Gropman AL.  Review of multi-modal imaging in urea cycle disorders: the old, the new, the borrowed, and the blue. Front Neurol. 2021;12:632307. 10.3389/fneur.2021.632307 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Weiss RJ, Bates SV, Song Y, et al.  Mining multi-site clinical data to develop machine learning MRI biomarkers: application to neonatal hypoxic ischemic encephalopathy. J Transl Med. 2019;17(1):385. 10.1186/s12967-019-2119-5 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80. Steiner M, Urlesberger B, Giordano V, et al.  Outcome prediction in neonatal hypoxic-ischaemic encephalopathy using neurophysiology and neuroimaging. Neonatology. 2022;119(4):483-493. 10.1159/000524751 [DOI] [PubMed] [Google Scholar]
  • 81. Troha Gergeli A, Škofljanec A, Neubauer D, Paro Panjan D, Kodrič J, Osredkar D.  Prognostic value of various diagnostic methods for long-term outcome of newborns after hypoxic-ischemic encephalopathy treated with hypothermia. Front Pediatr. 2022;10:856615. 10.3389/fped.2022.856615 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Aker K, Thomas N, Adde L, et al.  Prediction of outcome from MRI and general movements assessment after hypoxic-ischaemic encephalopathy in low-income and middle-income countries: data from a randomised controlled trial. Arch Dis Child Fetal Neonatal Ed. 2022;107(1):32-38. 10.1136/archdischild-2020-321309 [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from The British Journal of Radiology are provided here courtesy of Oxford University Press

RESOURCES